Abstract
A 69-year-old Japanese woman with acute myeloid leukemia underwent allogeneic peripheral blood stem cell transplantation from a human leukocyte antigen (HLA)-matched unrelated donor. After transplantation, tacrolimus was not discontinued because of persistent graft-versus-host disease (GVHD) of the liver. EGD performed 2 years after transplantation revealed no esophageal abnormalities except for reflux esophagitis. She described discomfort while swallowing 3 years after transplantation and received a diagnosis of chronic GVHD of the oral mucosa.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
